John B. Moriarty

Insider Reports History

Location
Alexion Pharmaceuticals, 352 Knotter Drive, Cheshire, CT
Signature
/s/ Michael F. MacLean, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John B. Moriarty:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avidity Biosciences, Inc. Chief Legal Officer Common Stock 47.8K $1.73M $36.21 Aug 4, 2025 Direct
Olema Pharmaceuticals, Inc. EVP, Ch. Legal Officer & Sec. Stock Option (Right to Buy) 150K Feb 1, 2023 Direct
Avidity Biosciences, Inc. Chief Legal Officer Stock Option (Right to Buy) 50K Jan 6, 2025 Direct
Mirati Therapeutics, Inc. Chief Legal Officer Common Stock 0 $59.02 Jan 23, 2024 Direct
Mirati Therapeutics, Inc. Chief Legal Officer Option to Purchase Common Stock 0 Jan 23, 2024 Direct

Insider Reports Filed by John B. Moriarty

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNA Avidity Biosciences, Inc. Aug 4, 2025 1 -$81.3K 4 Aug 5, 2025 Chief Legal Officer
RNA Avidity Biosciences, Inc. Jan 6, 2025 2 $0 4 Jan 8, 2025 Chief Legal Officer
RNA Avidity Biosciences, Inc. Aug 1, 2024 2 $0 4 Aug 5, 2024 Chief Legal Officer
RNA Avidity Biosciences, Inc. Aug 1, 2024 0 $0 3 Aug 5, 2024 Chief Legal Officer
MRTX Mirati Therapeutics, Inc. Jan 23, 2024 3 $0 4 Jan 23, 2024 Chief Legal Officer
MRTX Mirati Therapeutics, Inc. Aug 9, 2023 1 $825K 4 Aug 10, 2023 Chief Legal Officer
MRTX Mirati Therapeutics, Inc. Jun 23, 2023 0 $0 3 Jun 23, 2023 Chief Legal Officer
OLMA Olema Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 EVP, Ch. Legal Officer & Sec.
OLMA Olema Pharmaceuticals, Inc. Feb 1, 2022 1 $0 4 Feb 3, 2022 EVP, CH. LEGAL OFFICER & SEC.